Inducible Cancer Models (Therillume)
Oncology Research
Pre-clinicalActive
Key Facts
About Recombinetics
Recombinetics is a pioneering US-based biotechnology company specializing in gene editing for large animals, primarily swine and cattle. It operates a dual-market strategy, providing custom gene-edited swine models for preclinical biomedical research and developing agriculturally beneficial traits like disease resistance and heat tolerance in livestock. The company boasts a strong intellectual property portfolio, a history of industry 'firsts,' and is positioning itself for rapid growth in both the biomedical and agricultural sectors.
View full company profileTherapeutic Areas
Other Oncology Research Drugs
| Drug | Company | Phase |
|---|---|---|
| Biofabrication for Micro-tumors | Aurita Bioscience | Research-Use Only |
| Clear Dx® Platform | Clear Labs | Research-Use-Only |
| Target-Specific Assay Kits (e.g., HER2, PD-1/SHP-2) | Navinci Diagnostics | Commercial |